News and filings
-
Speech24 April 2024
2024 AGM: Chair's address
-
Press release08 April 2024
BAT and McLaren Racing announce multi-year partnership extension
-
Press release18 March 2024
Share buy-back programme
-
Press release13 March 2024
Completion of Block Trade of Ordinary Shares in ITC Limited
-
Press release12 March 2024
Launch of Proposed Block Trade of up to 436,851,457 Ordinary Shares in ITC Limited
-
Press release11 March 2024
BAT opens £30m Innovation Centre for New Category products in Southampton
-
Press release08 February 2024
Preliminary results for the year ended 31 December 2023
-
Press release06 February 2024
Board and Committee Changes
-
Press release02 February 2024
BAT and PMI Announce Global Patent Settlement
-
Press release10 January 2024
BAT launches Hyper Pro, its most innovative glo device yet
-
Press release06 December 2023
2023 Second Half Pre-Close Trading Update
-
Press release04 December 2023
Directorate Change
-
Press release27 November 2023
We need more regulation says UK’s largest vapour manufacturer
-
Press release06 November 2023
BAT to Strengthen Strategic Partnership with Organigram
-
Press release02 November 2023
BAT Appoints Chief Financial Officer
-
Press release13 October 2023
BAT Appoints Chief People Officer to the Management Board
-
Press release12 October 2023
BAT expresses disappointment at FDA Marketing Denial Order for Vuse Alto Menthol and Mixed Berry and will immediately seek a stay of enforcement
-
Press release20 September 2023
BAT outlines five-step plan towards better regulation of vapour sector
-
Press release14 September 2023
Russia business update – sale completed
-
Press release07 September 2023
Russia business update – agreement signed
-
Press release26 July 2023
Half-Year Report for the six months to 30 June 2023
-
Press release19 June 2023
BAT announces changes to Management Board structure and composition
-
Press release06 June 2023
2023 First Half Pre-Close Trading Update
-
Press release30 May 2023
New clinical data on Vuse illustrates beneficial public health impact of Tobacco Harm Reduction
-
Press release15 May 2023
BAT announces Tadeu Marroco as Chief Executive
-
Press release19 April 2023
2023 AGM: Chair's address
-
Press release09 February 2023
Preliminary announcement - year ended 31 December 2022
-
Press release01 February 2023
BAT included in prestigious 2023 Bloomberg Gender-Equality Index
-
Press release31 January 2023
Driving Faster Transformation at BAT: Management Board changes and a new regional structure
-
Press release24 January 2023
MDO for Vuse Vibe Tank Menthol 3.0% and Vuse Ciro Cartridge Menthol 1.5%
-
Press release17 January 2023
BAT recognised as a Global Top Employer for a sixth consecutive year
-
Press release15 December 2022
BAT celebrates inclusion in two leading global sustainability rankings
-
Press release13 December 2022
Reduced-risk* potential of Velo as cigarette alternative reinforced by innovative real-world study
-
Press release08 December 2022
2022 Second Half Pre-Close Trading Update
-
Press release14 November 2022
BAT invests in Charlotte’s Web, a leading US producer of hemp extract wellness products
-
Press release27 October 2022
BAT joins call for action on biodiversity
-
Press release04 October 2022
BAT publishes ambitious roadmap to reach Net Zero by 2050
-
Press release29 September 2022
BAT calls for collaboration to accelerate tobacco harm reduction
-
Press release26 September 2022
BAT announces Sanity Group investment
-
Press release06 September 2022
New study reveals positive long-term impact of switching from cigarettes to glo™
-
Press release30 August 2022
BAT appoints Chief Sustainability Officer
-
Press release28 July 2022
BAT’s ambitious 2030 decarbonisation target approved by SBTi
-
Stories and features27 July 2022
2022 Half-Year Results: highlights animation
-
Press release27 July 2022
Half-Year Report to 30 June 2022
-
Press release27 July 2022
BAT announces Board changes
-
Press release21 July 2022
BAT launches glo™ hyper X2: latest, state-of-the-art heated tobacco product
-
Press release09 June 2022
2022 First Half Pre-Close Trading Update
-
Press release06 June 2022
BAT conducts first real-world study assessing the impact of Vuse on indicators for several smoking-related diseases
-
Press release12 May 2022
Vuse Vibe and Vuse Ciro receive US FDA Marketing Authorization
-
Press release28 April 2022
BAT notes FDA announcement on product standard for menthol cigarettes
-
Speech28 April 2022
2022 AGM: Chairman's address
-
Press release11 March 2022
Russia business update and revised guidance
-
Press release09 March 2022
BAT statement on Ukraine/Russia
-
Press release22 February 2022
BAT to present at the 2022 Consumer Analyst Group of New York (CAGNY) conference
-
Press release17 February 2022
BAT appoints new Chief Medical Officer
-
Stories and features11 February 2022
Watch: 2021 results highlights animation
-
Press release11 February 2022
Share buyback programme
-
Press release11 February 2022
Preliminary announcement - year ended 31 December 2021
-
Press release11 February 2022
British American Tobacco announces Board changes
-
Press release20 January 2022
BAT recognised as Global Top Employer for fifth consecutive year
-
Press release19 January 2022
BAT launches virtual R&D Visitor Experience, showcasing the world-class science behind next generation reduced-risk nicotine products
-
Press release07 January 2022
BAT creates biotech company KBio to accelerate development of existing plant-based technology
-
Press release21 December 2021
BAT’s Vuse wins prestigious SEAL Sustainable Product Award
-
Press release07 December 2021
2021 Second Half Pre-close Trading Update
-
Press release30 November 2021
BAT statement on patent enforcement success in the U.S.
-
Press release15 November 2021
BAT in Dow Jones Sustainability Indices for 20th consecutive year - and only tobacco company in World Index
-
Press release15 October 2021
BAT announces commitment to set target for net zero emissions by 2050
-
Press release13 October 2021
Vuse Solo first to receive US FDA vapour marketing authorisation
-
Press release06 October 2021
2021 Annual General Meeting – Voting Results Update Statement
-
Press release30 September 2021
BAT's response to yesterday's U.S. International Trade Commission Final Determination
-
Press release13 September 2021
BAT emphatically rejects mischaracterisation of anti-illicit trade activities
-
Press release09 September 2021
BAT’s response to today’s FDA announcement
-
Press release08 September 2021
BAT’s Vuse becomes the number one global vaping brand
-
Press release28 July 2021
Half-Year Report to 30 June 2021
-
Press release22 July 2021
Vuse makes waves as the first global carbon neutral vape brand
-
Stories and features08 July 2021
Building A Better Tomorrow™. Responsibly
-
Press release01 July 2021
New study shows completely switching to BAT’s Tobacco Heating Product, glo, has similar impact on indicators of potential harm as quitting smoking
-
Press release08 June 2021
2021 First Half Pre-Close Trading Update
-
Press release28 May 2021
BAT’s Vuse becomes world’s first global carbon neutral vape brand
-
Press release28 May 2021
World Vape Day: BAT publishes comprehensive review highlighting 10 years of scientific evidence on vaping
-
Press release18 May 2021
BAT recognised as a Climate Leader by the Financial Times
-
Press release28 April 2021
2021 AGM: Chairman’s Statement
-
Press release01 April 2021
British American Tobacco Notice of Board Changes and Withdrawal of AGM Resolution
-
Press release11 March 2021
BAT enters strategic R&D collaboration to accelerate ‘beyond nicotine’ strategy with Organigram
-
Press release09 March 2021
BAT Unveils Ambitious New Environmental Targets in 2020 ESG Report
-
Press release01 March 2021
BAT launches ESG Week to amplify sustainability progress
-
Press release18 February 2021
BAT accelerates its enterprise transformation towards A Better Tomorrow™
-
Stories and features17 February 2021
FYR 2020: our transformation story in focus on CNBC
-
Press release17 February 2021
Preliminary announcement - year ended 31 December 2020
-
Stories and features16 February 2021
We strike gold again in sustainability
-
Press release25 January 2021
BAT recognised as Global Top Employer for fourth consecutive year
-
Press release19 January 2021
BAT announces succession for Director, Operations
-
Press release15 January 2021
SFO closes investigation into BAT
-
Stories and features11 January 2021
BAT launches first CBD vaping product
-
Press release16 December 2020
BAT progresses COVID-19 candidate vaccine into Phase I human clinical trials
-
Press release10 December 2020
BAT launches tobacco industry-first Human Rights Report
-
Press release09 December 2020
2020 Second Half Pre-close Trading Update
-
Press release08 December 2020
BAT awarded A-score and named in top 200 ‘A List’ companies for climate change action
-
Press release07 December 2020
British American Tobacco announces Board appointment
-
Press release19 November 2020
BAT recognised as a Financial Times Diversity Leader for second consecutive year
-
Press release16 November 2020
BAT named in Dow Jones Sustainability Indices for 19th consecutive year
-
Press release05 November 2020
New study finds that smokers switching exclusively to glo significantly reduce their exposure to certain toxicants, potentially reducing risk of smoking-related disease
-
Press release03 November 2020
BAT strengthens its US New Category portfolio: Announces acquisition of Dryft Modern Oral business
-
RNS22 October 2020
TR-1: Notification of major holdings
-
Press release15 October 2020
BAT to appoint new Chairman
-
Press release07 October 2020
2020 Annual General Meeting – Voting Results Update Statement
-
Science news29 September 2020
Laboratory tests indicate modern oral nicotine products elicit lower toxicity responses than cigarettes
-
Stories and features23 September 2020
Our CMO’s keynote speech at GTNF 2020
-
Press release23 September 2020
BAT advocates for a collaborative, stakeholder-inclusive approach to accelerate tobacco harm reduction
-
Science news18 September 2020
BAT Announces Appointment of Dr Hutan Ashrafian as Chief Medical Officer
-
Press release18 September 2020
BAT announces appointment of Dr Hutan Ashrafian as Chief Medical Officer
-
Press release11 September 2020
British American Tobacco announces Board appointment
-
Press release04 September 2020
BAT completes PMTA submissions for the broadest portfolio in the U.S.
-
Press release19 August 2020
BAT resumes sales in South Africa
-
Press release05 August 2020
British American Tobacco (“BAT”) announces new President for US business, Reynolds American
-
Press release31 July 2020
Half-year Report to 30 June 2020
-
Press release09 June 2020
2020 First Half Pre-Close Trading Update
-
Press release09 June 2020
BAT's response to WTO plain packaging decision
-
Press release15 May 2020
BAT makes progress on COVID-19 vaccine & provides community support
-
Press release30 April 2020
Chairman’s AGM Statement - 2020 outlook
-
Press release01 April 2020
BAT working on potential COVID-19 vaccine through US bio-tech subsidiary
-
Press release26 March 2020
BAT launches sustainability agenda to deliver A Better Tomorrow
-
Press release18 March 2020
BAT Capital Markets Webcast: Building A Better Tomorrow
-
Press release12 March 2020
British American Tobacco signs £6 billion SONIA and SOFR linked revolving credit facility
-
Press release27 February 2020
Preliminary announcement - year ended 31 December 2019
-
Press release13 February 2020
British American Tobacco named as one of the most sustainable companies in the world
-
Press release12 February 2020
British American Tobacco recognised as global leader for engaging its supply chain on climate change
-
Stories and features24 January 2020
Vype wins at Product of the Year awards again!
-
Press release20 January 2020
British American Tobacco named on CDP ‘A List’ for leading effort against climate change
-
Press release03 January 2020
British American Tobacco welcomes FDA guidance as a further step toward a sustainable regulatory environment for the U.S. vapour market
-
Stories and features28 November 2019
Simplifying our New Category brands
You might also be interested in
MORE IN:
Investors & Reporting
Related Articles
Follow us
Current UK share price
Contact us
BAT
Globe House
4 Temple Place
London
WC2R 2PG
+44 (0) 20 7845 1000